Table 4.
Antibacterial activity of compounds 1–7, 16–24.
| Compounds | MIC (μg/mL) | |||
|---|---|---|---|---|
| SA | MRSA | E. coli | Xcc | |
| 1 | >1,000 | >1,000 | >1,000 | >1,000 |
| 2 | 12.5 | 3.1 | 125 | 12.5 |
| 3 | 250 | 500 | 1,000 | 125 |
| 4 | >1,000 | >1,000 | >1,000 | 250 |
| 5 | >1,000 | >1,000 | >1,000 | 125 |
| 6 | >1,000 | >1,000 | >1,000 | 250 |
| 7 | >1,000 | >1,000 | >1,000 | 250 |
| 16 | 500 | 500 | 1,000 | 250 |
| 17 | >1,000 | 1,000 | 1,000 | >1,000 |
| 18 | 1,000 | 1,000 | 1,000 | 1,000 |
| 19 | 250 | 250 | 1,000 | 125 |
| 20 | >1,000 | >1,000 | >1,000 | 500 |
| 21 | 1,000 | 1,000 | 1,000 | 500 |
| 22 | 250 | 250 | 1,000 | 125 |
| 23 | >1,000 | >1,000 | >1,000 | 1,000 |
| 24 | >1,000 | >1,000 | >1,000 | 1,000 |
| Vancomycin | 0.63 | 1.25 | / | / |
| Polymyxin B | / | / | 2.5 | / |
| CuSO4 | / | / | / | 125 |